FindTrial
Sign In

Programmed cell death ligand 1 expression and clinical correlation in epithelial ovarian carcinoma patients

Programmed cell death ligand 1 expression and clinical correlation in epithelial ovarian carcinoma patients

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
TCTR
Registry ID
TCTR20161115004
Enrollment
92
Registered
2016-11-15
Start date
2016-11-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epithelial Ovarian Carcinoma patients Ovary&#44

Interventions

PDL1 expression in EOC patients
Diagnostic
Epithelial Ovarian Carcinoma

Sponsors

Siriraj Research Development Fund
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patients who are suspected Ovarian cancer and admit for primary surgical treatment • Age ≥ 18 years and can use Thai and sign in consent form

Exclusion criteria

Exclusion criteria: Final pathology is not epithelial ovarian carcinoma

Design outcomes

Primary

MeasureTime frame
Prevalence of PDL1 expression in EOC 1 year rate in percent—

Secondary

MeasureTime frame
Correlation of Immunohistochemistry and mRNA expression 1.5 year Logistic Regression Analysis—

Countries

Thailand

Contacts

Public ContactAchjima Tankul

Gynecologic Oncology Division, Obstetrics and Gynecology Department, Faculty of Medicine Siriraj Hos

achjimink@gmail.com0819565006

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026